Danielle Pillsbury

Announcement

Ghent University wins the 2021/22 Certara-Simcyp Grant and Partnership Scheme

PRINCETON, N.J., 2023 年 1 月 9 日 — Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation,…

Danielle Pillsbury2023 年 1 月 9 日

Blog

New FDA Requirement to Support Labeling on DDIs in the Pediatric Population

The effects of drug-drug interactions (DDIs) could differ in the pediatric population compared to adults.…

Danielle Pillsbury2022 年 12 月 21 日

Blog

The Phoenix Workflow Shortcuts Every Pharmacokineticist Needs

Certara’s Phoenix™ Pharmacokinetic and Pharmacodynamic (PK/PD) Platform can revolutionize your pharmaceutical organization’s approach to PK/PD…

Danielle Pillsbury2022 年 12 月 16 日

Article

Accelerating Market Access with Data-Driven Payer Engagement

Using data visualizations to improve access to payers. With the switch to more digital environments,…

Danielle Pillsbury2022 年 10 月 25 日

Pediatrician examining cute baby in clinic, closeup

On-Demand Webinar

Applications of PBPK modelling for regulatory submissions: case studies involving DDIs, transporters and special populations

Over the past two decades, there have been transformative changes in our approach to using…

Danielle Pillsbury2022 年 10 月 20 日

Fact Sheet

PK Submit™ 概览

了解 PK Submit™ 如何加速 NCA 工作流并确保符合监管要求

Danielle Pillsbury2022 年 10 月 12 日

Announcement

Certara Announces New Release of PK Submit

PRINCETON, N.J.— 2022 年 10 月 12 日 – Certara, Inc., a global leader in drug development software,…

Danielle Pillsbury2022 年 10 月 12 日

White Paper

推动欧洲罕见病治疗的普及

Danielle Pillsbury2022 年 7 月 11 日

On-Demand Webinar

Exploring Changes in SDTMIG 3.4 & ADaMIG 1.3

On November 29th 2021, CDISC released updated versions of SDTM and ADaM, including standardized structures…

Danielle Pillsbury2021 年 12 月 16 日

Blog

Pediatric Drug Development: Optimizing Extrapolation

Drug development in pediatrics continues to be a substrate for the application of innovative tools…

Danielle Pillsbury2021 年 9 月 1 日

Danielle Pillsbury

Ghent University wins the 2021/22 Certara-Simcyp Grant and Partnership Scheme

New FDA Requirement to Support Labeling on DDIs in the Pediatric Population

The Phoenix Workflow Shortcuts Every Pharmacokineticist Needs

Accelerating Market Access with Data-Driven Payer Engagement

Applications of PBPK modelling for regulatory submissions: case studies involving DDIs, transporters and special populations

PK Submit™ 概览

Certara Announces New Release of PK Submit

推动欧洲罕见病治疗的普及

Exploring Changes in SDTMIG 3.4 & ADaMIG 1.3

Pediatric Drug Development: Optimizing Extrapolation

订阅时事通讯

快捷链接

解决方案

联系我们